Together, our findings indicate that S. aureus infection may activate EGFR-MEK1/2 signaling, thereby suppressing mitochondrial ROS levels by downregulating Chek2 expression, leading to the progression of S. aureus osteomyelitis in mice. The gene discussed is CHEK2; the disease is osteomyelitis.